Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia

NCT04895488 is registered in ClinicalTrials.gov with Fundación Pública Andaluza para la gestión de la Investigación en Sevilla as lead sponsor.

NCT NCT04895488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04895488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Effects of Adjuvant Vortioxetine in Early Schizophrenia
Lead sponsor
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase
Phase 2/3
Overall status
Unknown status
Start date
January 20, 2022
Completion date
December 20, 2025
Enrollment
37 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment with primary psychotic disorder, negative symptoms with primary psychotic disorder